About
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Research context
Johnson & Johnson appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Johnson & Johnson is currently in a long term uptrend where the price is trading 6.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.3.
Johnson & Johnson's total revenue rose by 8.3% to $22B since the same quarter in the previous year.
Its net income has dropped by 56.7% to $2B since the same quarter in the previous year.
Finally, its free cash flow grew by 36.6% to $7B since the same quarter in the previous year.
Based on the above factors, Johnson & Johnson gets an overall score of 4/5.
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 9 months ago
5 years, 10 months ago
5 years, 10 months ago
5 years, 10 months ago